Kiora Pharmaceuticals, Inc. (KPRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.21M |
| Enterprise Value | -119,927 |
| P/E Ratio | -1.07 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.41 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.46 |
| Return On Equity | -0.63 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -24,801 |
| EBITDA | -12.07M |
| Net Income | -10.84M |
| Diluted EPS | -2.64 |
Balance Sheet
| Total Cash | 16.84M |
| Total Cash/Share | 2.73 |
| Total Debt | 333,022 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 8.97 |
| Book Value Per Share | 2.73 |
Price History
| 52-Week Change | 5.6 |
| 52-Week High | 3.01 |
| 52-Week Low | 1.77 |
| Moving Average 50 Days | 2.57 |
| Moving Average 200 Days | 2.31 |
Statistics
| Average Volume | 28,087 |
| Shares Outstanding | 4.43M |
| % Held by Institutions | 1.12 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | June 11, 2024 |
AD
